Population
14,062 new users of antihypertensive drugs, ≥20 years of age, receiving a first prescription for diuretics…
Design
Cohort
Follow-up
365 days
Authors
Loading...
Low persistence may drive disproportionate antihypertensive costs; leaves open whether adherence interventions improve outcomes or reduce spending.
A low proportion (39.7%) of new antihypertensive users remain on treatment at 1 year, highlighting a significant gap in medication persistence that disproportionately drives overall drug costs.
Esposti et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: